Your shopping cart is currently empty

Pixatimod (also known as PG-545) is a synthetic carbohydrate-modified heparan sulfate mimetic and a Toll-like receptor 9 (TLR9) agonist. It exhibits potential immunostimulatory, antitumor, and antiviral effects. Pixatimod effectively inhibits SARS-CoV-2 by disrupting the spike protein-ACE2 interaction. Additionally, it blocks various cancer-promoting processes such as cell proliferation, invasion, metastasis, angiogenesis, and epithelial-mesenchymal transition. These effects have demonstrated significant efficacy in numerous mouse cancer models, including about 30 xenograft models and 20 syngeneic models. Pixatimod has been tested in combination with several approved anticancer compounds, showing clinical potential when used with gemcitabine, paclitaxel, sorafenib, platinum compounds, and anti-PD-1 antibodies.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Pixatimod (also known as PG-545) is a synthetic carbohydrate-modified heparan sulfate mimetic and a Toll-like receptor 9 (TLR9) agonist. It exhibits potential immunostimulatory, antitumor, and antiviral effects. Pixatimod effectively inhibits SARS-CoV-2 by disrupting the spike protein-ACE2 interaction. Additionally, it blocks various cancer-promoting processes such as cell proliferation, invasion, metastasis, angiogenesis, and epithelial-mesenchymal transition. These effects have demonstrated significant efficacy in numerous mouse cancer models, including about 30 xenograft models and 20 syngeneic models. Pixatimod has been tested in combination with several approved anticancer compounds, showing clinical potential when used with gemcitabine, paclitaxel, sorafenib, platinum compounds, and anti-PD-1 antibodies. |
| Synonyms | CHEMBL2059499, 99N289ZQ8L |
| Molecular Weight | 2363.82 |
| Formula | C51H75Na13O60S13 |
| Cas No. | 1144492-69-2 |
| Smiles | C[C@@]12[C@]3([H])[C@](CC[C@@]1([H])C[C@H](CC2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COS(=O)([O-])=O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)([O-])=O)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COS(=O)([O-])=O)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)COS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)([H])[C@@]8([H])[C@](CC3)([C@@](CC8)([H])[C@H](C)CCCC(C)C)C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.